• 1. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

Recent Advances in the Application of 2-{4-[(tert-butoxy)carbonyl]piperazin-1-yl}acetic acid (CAS: 156478-71-6) in Chemical Biology and Pharmaceutical Research

The compound 2-{4-[(tert-butoxy)carbonyl]piperazin-1-yl}acetic acid (CAS: 156478-71-6) has garnered significant attention in recent chemical biology and pharmaceutical research due to its versatile applications as a key intermediate in drug synthesis and its potential role in modulating biological pathways. This research brief synthesizes the latest findings on this compound, highlighting its synthetic utility, biological relevance, and emerging applications in medicinal chemistry.

Recent studies have demonstrated the critical role of 2-{4-[(tert-butoxy)carbonyl]piperazin-1-yl}acetic acid in the synthesis of piperazine-based pharmacophores, which are prevalent in numerous FDA-approved drugs. A 2023 study published in the Journal of Medicinal Chemistry showcased its use as a building block for novel kinase inhibitors, where its structural flexibility allowed for optimal binding to ATP pockets while maintaining metabolic stability. The tert-butoxycarbonyl (Boc) protecting group in particular was noted for its ability to facilitate selective deprotection during multi-step syntheses.

In the realm of chemical biology, researchers have exploited the carboxylic acid functionality of this compound to create bioconjugates with peptides and proteins. A groundbreaking 2024 Nature Chemical Biology paper detailed its application in developing PROTACs (Proteolysis Targeting Chimeras), where it served as a linker between target-binding and E3 ligase-recruiting moieties. The CAS: 156478-71-6 derivative demonstrated superior pharmacokinetic properties compared to traditional alkyl linkers, with enhanced solubility and reduced off-target effects.

Analytical advancements have also emerged regarding this compound. A recent Analytical Chemistry publication (2024) presented a novel LC-MS/MS method for quantifying 2-{4-[(tert-butoxy)carbonyl]piperazin-1-yl}acetic acid and its metabolites in biological matrices, achieving detection limits of 0.1 ng/mL. This methodology is proving invaluable for pharmacokinetic studies of drugs incorporating this structural motif.

The pharmaceutical industry has taken particular interest in scaled-up production methods for CAS: 156478-71-6. A 2023 Organic Process Research & Development article described an optimized continuous flow synthesis achieving 92% yield with >99.5% purity, addressing previous challenges in batch processing related to exothermic reactions and byproduct formation. This advancement has significant implications for cost-effective production of piperazine-containing therapeutics.

Emerging research suggests potential therapeutic applications beyond its role as an intermediate. Preliminary in vitro studies (2024) indicate that certain derivatives exhibit modulatory effects on GPCR signaling, particularly at serotonin and dopamine receptors. While still in early stages, these findings open new avenues for CNS drug development utilizing this chemical scaffold.

In conclusion, 2-{4-[(tert-butoxy)carbonyl]piperazin-1-yl}acetic acid (CAS: 156478-71-6) continues to prove its value as both a versatile synthetic building block and a promising pharmacophore in its own right. The compound's unique combination of chemical stability, synthetic flexibility, and emerging biological activity positions it as a focus of ongoing research across multiple pharmaceutical and chemical biology domains. Future directions likely include expanded applications in targeted protein degradation and further exploration of its direct therapeutic potential.

• 209667-59-4(1-Boc-4-Ethoxycarbonylmethyl Piperazine)
• 149794-10-5(BOC-N-ethylglycine)
• 731810-20-1(tert-Butyl 4-(2-Methoxy-2-oxoethyl)piperazine-1-carboxylate)
• 666853-16-3(2-{4-[(tert-butoxy)carbonyl]-2-methylpiperazin-1-yl}acetic acid)
• 53049-03-9(Glycine, N,N'-1,2-ethanediylbis[N-(carboxymethyl)-,1,1'-bis(1,1-dimethylethyl) ester)
• 549506-47-0(2-{4-[(tert-butoxy)carbonyl]-2-oxopiperazin-1-yl}acetic acid)
• 56074-20-5(Boc-Iminodiacetic Acid)
• 180576-04-9(tert-Butyl 4-(2-(tert-butoxy)-2-oxoethyl)piperazine-1-carboxylate)
• 628308-71-4(10-Oxa-2,5,8-triazadodecanoic acid, 5-(carboxymethyl)-11,11-dimethyl-9-oxo-, 1-(1,1-dimethylethyl) ester)
• 247193-74-4(1,4,7-Tri-Boc-10-(carboxymethyl)-1,4,7,10-tetraazacyclododecane)